FPH

Fisher & Paykel Healthcare Corporation Ltd

FPH.AU fphcare.com + Research + Basket
ISIN NZFAPE0001S2
Employees 7,357
Phone 64 9 574 0100
Fiscal year end March
Address 15 Maurice Paykel Place, Auckland, New Zealand, 2013
39.03
-0.57 (-1.44%)
AUD · AU
52-week range
26.28
40.15
Trading at 92% of the 52-week range
Market Cap
22.96B
P/E Ratio
55.76
Forward P/E
52.36
Book Value
2.92
Div. Yield
1.31%
% Institutions
38.62%
% Insiders
3.69%

1 Year

+28.5%

3 Year

+112.3%

10 Year

+447.8%
Description

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Actions

Add an action for FPH.AU, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Mr. Lewis G. Gradon MD, CEO & Executive Director 1961
Ms. Lyndal York Chief Financial Officer NA
Mr. Andy Niccol Chief Operating Officer NA
Dr. Andrew Somervell Vice President of Products & Technology NA
Mr. Daniel Adolph Head of Investor Relations NA
Ms. Raelene Leonard Company Secretary & General Counsel NA
Ms. Karen Knott General Manager of Corporate Communications NA
Mr. Justin Callahan VP of Sales & Marketing NA
Ms. Nicola Talbot Vice President of Human Resources NA
Mr. Jonathan Rhodes Vice President ? Network Design, Facilities, Infrastructure & Sustainability NA

Shareholders

▼

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard International Stock Index-Total Intl Stock Indx 8.75M 1.52% N/A Oct 31, 2020
2 Price (T.Rowe) International Discovery Fund 5.37M 0.93% N/A Jan 31, 2021
3 Smallcap World Fund 4.72M 0.82% N/A Dec 31, 2020
4 Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund 3.62M 0.63% N/A Dec 31, 2020
5 Invesco Oppenheimer International Small-Mid Company Fund 2.85M 0.49% N/A Jan 31, 2021
6 New Perspective Fund Inc 2.70M 0.47% N/A Dec 31, 2020
7 iShares Core MSCI EAFE ETF 2.61M 0.45% N/A Feb 28, 2021
8 American Funds Insurance Ser-Global Growth Fund 2.55M 0.44% N/A Dec 31, 2020
9 Columbia Acorn International Fund 2.01M 0.35% N/A Dec 31, 2020
10 iShares MSCI Eafe ETF 1.90M 0.33% N/A Feb 28, 2021

Financial Highlights

▼
Market Cap: $22.96B
EBITDA: $759.40M
P/E Ratio: $55.76
PEG Ratio: $4.47
Book Value: $2.92
Dividend/Share: $0.52
Dividend Yield: 1.31%
Earnings/Share: $0.70
Profit Margin: 20.30%
Operating Margin: 28.72%
ROA (TTM): 14.72%
ROE (TTM): 23.39%
Revenue (TTM): $2.31B
Revenue/Share (TTM): $3.93
Earnings Growth (YOY): 14.30%
Revenue Growth (YOY): 14.00%

Valuation Metrics

Enterprise Value: $23.03B
Trailing P/E: 55.76
Forward P/E: 52.36

Shares Statistics

Shares Outstanding: 588.27M
Shares Float: 584.99M
% Insiders: 3.69%
% Institutions: 38.62%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$2.36B
Cost of Goods Sold
adjust
$-844.40M
Gross Profit
subtotal
$1.51B
SG&A
adjust
$-598.20M
R&D
adjust
$-237.21M
Other Operating Expense
adjust
$-4.36M
Operating Income
subtotal
$671.86M
Other / Non-Operating Items
adjust
$-199.95M
Net Income
subtotal
$471.91M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about FPH.AU!